Scar Treatment Market By Product Type (Topical Products {Creams, Gels, Silicon Sheets, Others} Invasive Treatments {Laser treatments [CO2 Laser, Pulse-dyed Laser, Others] Dermabrasion, Injectables} Others), By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Acne Scars, Contracture Scars, Stretch Marks, Burn Scars, Others), By End-User (Hospitals, Clinics, Home Care), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Nov 2024 | Report ID: MI1427 | 220 Pages

Industry Outlook

The Scar Treatment market accounted for USD 18.8 Billion in 2024 and is expected to reach USD 63.5 Billion by 2035, growing at a CAGR of around 11.7% between 2025 and 2035.  The scar treatment market refers to the industry that focuses on products and services designed to decrease, remove, or make the scar appear better. Included in this market is a wide range of treatments that can be topical creams and gels or silicone sheets, all the way to more advanced therapies like laser treatments, dermal fillers, and surgeries.

Scars can be caused by accidents, surgeries, acne, burns, or skin conditions, thereby giving rise to the need for solutions that address cosmetic issues or functional disability caused by scars. An increase in the market is also encouraged by other related factors such as increased awareness, upgraded technology in scar healing, and an increased interest in aesthetics. It also includes both OTC remedies as well as professional treatments. With a wide consumer base, the market in developed and emerging economies is growing with the demand to have better skin appearance and health.

Report Scope:

ParameterDetails
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2024
Market Size in 2024USD 18.8 Billion
CAGR (2025-2035)11.7%
Forecast Years2025-2035
Historical Data2018-2024
Market Size in 2035USD 63.5 Billion
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa
What We CoverMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and over 10 companies
Segments CoveredProduct Type, Scar Type, End-User, and Region

To explore in-depth analysis in this report - Request Free Sample Report

Market Dynamics

Rising Demand for Scar Treatments Driven by Aesthetic Concerns and Increased Awareness

There is an increasing aesthetic concern from people, especially when it comes to their consciousness of personal appearances and their longing for silky-smooth skin. The NIH indicates that about 40% of the population has scars that are visible to the public, which would negatively influence self-confidence, thus increasing the demand for cosmetic dermatological solutions.

According to the American Society for Dermatologic Surgery, 70% of patients are concerned about the appearance of scars, thereby motivating a higher percentage of patients to present for the treatment. Of all the reasons for doctor visits, skin diseases rank high as the most common reason for visiting the doctor, according to the CDC.

Government initiatives like schemes promoting access to dermatology services through Medicaid and Medicare have provided these treatments to more members of society. Public awareness programs related to skin health have also sparked more interest in non-invasive procedures and, therefore, in scar treatments.

Growth in Surgical Procedures Boosts Demand for Scar Treatment Solutions

There is a higher prevalence of surgeries leading to demand for scar treatments. The Centers for Disease Control and Prevention report that around 48 million surgical procedures are conducted annually in the U.S., and most leave scars. The NIH puts forward that among the most common forms of scars prevalent in most patients include surgical scars, which run into millions of patients treated annually. Data from the American Society of Plastic Surgeons also indicates that the number of cosmetic surgeries being done in the U.S. has increased steadily, with more than 18 million procedures in 2020 alone.

The more people undergo surgery be it for medical reasons or cosmetic enhancement, the greater the demand for effective scar treatments. Government health initiatives like increased coverage under Medicaid and Medicare, have made scar treatment much more accessible and continued to fuel market growth. This pattern clearly indicates the increasing need for sophisticated approaches to deal with post-surgical scars.

High Treatment Costs Limit Accessibility to Advanced Scar Treatments

The treatment for more advanced scar treatments like lasers or surgical procedures, poses a great barrier to accessibility in the hands of many patients. According to the American Society for Aesthetic Plastic Surgery on average, laser scar removal costs between $1,000 and $3,000 per session, which would be too expensive for many patients without further insurance coverage.

As per the CMS report, these programs generally cover some treatments, but most advanced scar therapies are not in the standard coverage packages meaning that most of people spend their money out of pocket. This is further added by the NIH, saying that most uninsured or underinsured end up struggling financially when they need effective scar treatment and thus limit their access. This financial barrier coupled with limited insurance coverage, restricts market growth and inhibits access to proper scar treatments for those who might need it most.

Rising Demand for Post-Acne Scar Treatments Driven by Increased Awareness and Prevalence

The CDC promotes its health-related initiatives, emphasizing the importance of skin health and creating heightened awareness and access to treatments for acne scars. This developing interest in acne care is an important opportunity for the scar treatment market. Along with a high prevalence of acne, growing awareness about post-acne scar treatments has already triggered an escalating demand for efficient solution, mainly among teenagers and young adults.

The American Academy of Dermatology has reported that annually, acne affects nearly 50 million Americans, and most people fall between the ages of 12 and 24 years. According to NIH, up to 80% of people experience acne at some point in their lives, which means there is a large population in need of treatments targeting post-acne scarring. With an increased awareness of available treatment options, more patients will seek solutions, and therefore, drive greater demand for scar treatments.

Opportunities in Scar Prevention Products for New Mothers

The new market of scar-preventing products for new mothers is a unique opportunity, especially for those who have experienced stretch marks or C-section scars. As reported by the Centers for Disease Control and Prevention (CDC), nearly 1 in 3 women in the U.S. give birth via C-section, thus affecting many women who require scar treatments.

According to ACOG, up to 90% of pregnant women experience stretch marks, which means this is a vast potential market for scar prevention products. As more mothers are getting informed on scar treatments, more demand is being made for post-baby scar solutions. Initiatives in respect of government concerning maternal health, such as those implemented by the NIH, provide support towards awareness and inclusiveness of products related to enhancing post pregnancy skin health.

This is a promising niche market for scar prevention and treatment products due to demographic shift and focus on maternal well-being.

Industry Experts Opinion

"This technology not only enhances the precision of our diagnostics but also reinforces our ability to meet the unique skincare needs of each individual. It represents a significant leap forward in our mission to provide effective, tailored solutions that empower our customers to achieve healthy skin."

  • Rajiv Nair, CEO, Kaya India.

Segment Analysis

Based on the product type, the Scar Treatment market has been classified into Topical Products, Invasive Treatments, and Injectables. The Scar Treatment market is further segmented by Topical Products into Creams, Gels, Silicon Sheets, and Others. Based on Invasive Treatments, the market is further classified into Laser Treatments, including CO2 Laser, Pulse-dyed Laser, and Others, along with Dermabrasion. Injectables include various treatment options, along with Other related products.

 

The Scar Treatment market is classified into Atrophic Scars, Hypertrophic & Keloid Scars, Acne Scars, Contracture Scars, Stretch Marks, Burn Scars, and Others. Acne Scars lead due to the high prevalence of acne, particularly among teens and young adults.

Regional Analysis

North America is the largest market for scar treatments, primarily because of high awareness of aesthetic procedures and a highly developed infrastructure for healthcare. In the U.S., in particular, there is considerable demand for scar treatments due to the preponderance of acne, surgical procedures, and various types of skin injuries.

There is also the influence of cutting-edge technologies in treatment like laser therapies and injectables. In the Asia-Pacific region, strong market players and the presence of vast insurance coverage for aesthetic treatments augment the growth of the market in this region. Further, there is growing consumer interest in non-invasive treatments, which supports market expansion.

Asia-Pacific is the fastest-growing market for scar treatments due to the growing middle-class population, increasing disposable incomes, and growing awareness of aesthetic procedures. China, India, and Japan see growing needs for scar treatments in urban locations, largely because the incidence of acne, burns, and surgery, which are typically more prevalent there, has increased.

In this region, market growth is further accelerated by the rising acceptance of advanced technologies, and medical tourism. The rapid growth is further driven by a shift toward more preventive care as well as treatments adapted to particular needs of the skin. Additionally, the growing popularity of social media and the influence of beauty standards have led to increased demand for cosmetic treatments. The region's expanding healthcare infrastructure also ensures broader access to scar treatment options.

Competitive Landscape

The competitive landscape of the scar treatment market is highly dynamic, and for the growth momentum, the players in this market are driving through innovation and strategic initiatives. Some of the most prominent companies leading the market include Medytox, Inc., Hugel, Inc., and Cynosure, Inc., offering a complete range of scar treatment solutions from advanced lasers, topical products, and injectables.

A prime example of recent advancements is Crown Aesthetics taking over Cavendish Clinics in the UK for the SkinPen® Precision Microneedling System in November 2024. BRIJ Medical launched Brijjit® Scar Therapy in September 2024, which marks an important step forward from reactive scar treatment to a more proactive approach to scar prevention, as it further strengthens emerging companies' market involvement. As such, the market is expected to grow steadily with established and new entrants into the market as these companies continue their innovation in new treatment options and expanded product offerings.

Scar Treatment Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

  • In Nov. 2024, Crown Aesthetics announced that Cavendish Clinics in the UK upgraded to the SkinPen® Precision Microneedling System, enhancing treatments for acne scars, wrinkles, stretch marks, surgical scars, and more.
  • In Sept. 2024, BRIJ Medical launched Brijjit® Scar Therapy, a solution that helps surgeons grow their practice and allows patients to manage scar prevention throughout wound healing.
  • In September 2024, Kaya Clinic launched India’s first AI-powered app for personalized skin diagnosis, offering tailored insights into skin issues.
  • In March 2024, Allergan Aesthetics announced U.S. FDA approval for JUVÉDERM® VOLUMA® XC to treat moderate to severe temple hollowing in adults over 21, with results lasting up to 13 months.

Report Coverage:

By Product Type

  • Topical Products
    • Creams
    • Gels
    • Silicon Sheets
    • Others
  • Invasive Treatments
    • Laser treatments
      • CO2 Laser
      • Pulse-dyed Laser
      • Others
    • Dermabrasion
    • Injectables
  • Others

By Scar Type

  • Atrophic Scars
  • Hypertrophic & Keloid Scars
  • Acne Scars
  • Contracture Scars
  • Stretch Marks
  • Burn Scars
  • Others

By End-User

  • Hospitals
  • Clinics
  • Home Care

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Medytox, Inc.
  • Hugel, Inc.
  • Kelo-Cote
  • Cynosure, Inc.
  • Smith & Nephew PLC
  • Suneva Medical, Inc.
  • Revance Therapeutics, Inc.
  • Bausch Health
  • Avita Medical
  • Molnlycke
  • Laboratoires Genevrier
  • Beiersdorf AG
  • Procter & Gamble Co.
  • Stratpharma AG
  • Enaltus LLC

Frequently Asked Questions (FAQs)

The Scar Treatment market accounted for USD 18.8 Billion in 2024 and is expected to reach USD 63.5 Billion by 2035, growing at a CAGR of around 11.7% between 2025 and 2035.

Key growth opportunities in the Scar Treatment Market include the increasing demand for non-invasive treatments and the rising awareness of advanced scar therapies, especially in emerging markets. Additionally, the growing prevalence of acne, surgical procedures, and burns offers significant market potential.

The largest segment in the Scar Treatment Market is topical products, including creams and gels, driven by high consumer demand for non-invasive solutions. The fastest-growing segment is invasive treatments, particularly laser therapies and injectables, due to advancements in technology and increased adoption.

North America will make a notable contribution to the Global Scar Treatment Market, driven by high demand for advanced treatment options, strong healthcare infrastructure, and high consumer awareness. The U.S., in particular, sees significant growth due to the prevalence of acne, surgical procedures, and a growing preference for non-invasive cosmetic treatments.

Leading players in the global Scar Treatment Market include Suneva Medical, Revance Therapeutics, Bausch Health, and Molnlycke Health Care, driving growth through innovative injectables, laser treatments, and topical products.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.